CCNB2 and non-small cell lung carcinoma: Gong et al. (2021) found that CCNB2 was associated with shorter overall survival in patients of non-small cell lung cancer (NSCLC) by bioinformatic analysis and confirmed the upregulation of CCNB2 in NSCLC tissues in cell experiments.